- Home
- NMRA vs GDEV Comparison
NMRA vs GDEV Comparison
Compare NMRA & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- GDEV
- Stock Information
- Founded
- NMRA 2019
- GDEV 2009
- Country
- NMRA United States
- GDEV Cyprus
- Employees
- NMRA N/A
- GDEV N/A
- Industry
- NMRA
- GDEV EDP Services
- Sector
- NMRA
- GDEV Technology
- Exchange
- NMRA Nasdaq
- GDEV Nasdaq
- Market Cap
- NMRA 291.5M
- GDEV 266.7M
- IPO Year
- NMRA 2023
- GDEV N/A
- Fundamental
- Price
- NMRA $3.01
- GDEV $22.59
- Analyst Decision
- NMRA Buy
- GDEV
- Analyst Count
- NMRA 8
- GDEV 0
- Target Price
- NMRA $7.43
- GDEV N/A
- AVG Volume (30 Days)
- NMRA 3.0M
- GDEV 9.3K
- Earning Date
- NMRA 11-06-2025
- GDEV 11-14-2025
- Dividend Yield
- NMRA N/A
- GDEV N/A
- EPS Growth
- NMRA N/A
- GDEV 12.96
- EPS
- NMRA N/A
- GDEV 2.56
- Revenue
- NMRA N/A
- GDEV $425,112,000.00
- Revenue This Year
- NMRA N/A
- GDEV N/A
- Revenue Next Year
- NMRA N/A
- GDEV $1.39
- P/E Ratio
- NMRA N/A
- GDEV $8.82
- Revenue Growth
- NMRA N/A
- GDEV N/A
- 52 Week Low
- NMRA $0.61
- GDEV $8.60
- 52 Week High
- NMRA $14.09
- GDEV $42.20
- Technical
- Relative Strength Index (RSI)
- NMRA 75.77
- GDEV 45.57
- Support Level
- NMRA $2.40
- GDEV $21.74
- Resistance Level
- NMRA $3.25
- GDEV $25.76
- Average True Range (ATR)
- NMRA 0.27
- GDEV 1.62
- MACD
- NMRA 0.11
- GDEV -0.54
- Stochastic Oscillator
- NMRA 84.76
- GDEV 34.89
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.